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The carcinogenic properties of the sunburn
rays are well-documented (1). However, their
effect on tumors produced by chemical car-
cinogens remains unsettled. This study specifically
examines the issue: can repeated small doses of
ultraviolet light rays shorter than 3200 A
promote chemically induced tumor formation.
Previous studies have been frustrated by the
lack of a suitable method for the separation of the
carcinogenic effects of chemical carcinogens from
those of ultraviolet light energy. Complicating
factors have included time-dose relationships,
hair cycle effects, alteration of the chemical
carcinogen by light energy, photo-recovery, and
photosensitization by the carcinogen. The two-
stage concept of chemical tumor formation
suggested a technic for separating the variables
that have hindered examination of this problem
(2, 3, 4).
MATERIAL5 AND METHODS
Animals: Inbred Swiss strain albino mice were
housed in metal cages and fed on unrestricted
quantities of Wayne Laboratory Blox and water.
Natural sunlight was excluded; artificial light ex-
posure was minimal except during observation
and treatment.
Carcinogen: A solution 0.5 per cent of 9:10
dimethyl—1:2 benzanthracenc (DMBA) in acetone
was prepared just prior to use.
Light Source: An Hanovia air-cooled hot quartz,
high pressure, contact lamp at the onset produced
1.73 X 10 ergs per square centimeter of mid-ultra-
violet light (2800 A to 3200 A) at a distance of 3.4
cm. At the end of the study the lamp produced
1.02 ergs per square centimeter of this energy. Fre-
quent measurements were made with an Hanovia
ultraviolet meter (Model AV-971) to establish
the total energy applied.
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Experimental Design (Table I)
At the onset of the experimental procedure, the
pellage was determined to be in the growing stage
of the hair cycle by the Boron dye method (5).
The animals were divided into three groups. Group
I received one application of DMBA in acetone
followed by low dose ultraviolet light exposures
twice weekly for 67 weeks; Group II received one
DMBA application alone; and Group III received
one application of acetone followed by ultraviolet
exposures as in Group I. The hair was clipped with
scissors and a biopsy examination was done on the
posterior half of the right side of the back just
prior to the single application of the DMBA or
acetone. Further hair clipping was done prior to
ultraviolet exposures when necessary to assure
direct skin exposure.
Method
Group I (DMBA plus UVL) consisted of 31
mice, 14 to 16 weeks old (15 male and 16 female).
Two drops (0.1 ml.) of the 0.5 per cent solution of
DMBA were applied to the posterior half of the
backs of each mouse. Fourteen days later, bi-
weekly ultraviolet light exposures of the DMBA
treated areas were initiated and continued for 67
weeks (a total of 13.33 X 10 ergs per square centi-
meter of mid-ultraviolet light energy).
Group II (DMBA without UVL) consisted of 41
mice, 14 to 18 weeks old (19 male and 22 female),
which were treated with DMBA as in Group I,
but they received no ultraviolet light.
Group III (acetone plus UVL) consisted of 47
mice, 11 to 14 weeks old (31 male and 16 female).
Acetone, 0.1 ml., was applied to the posterior
half of the back of each mouse. The ultraviolet
light exposures were initiated fourteen days later
and completed as in Group I (13.33 X 10 ergs per
square centimeter of mid-ultraviolet light energy
in67 weeks).
EE5ULT5
1. Reaction to DMBA (Table II)
Hair loss and thickening of the treated skin
appeared in all of the mice by eleven days after
the application of DMBA (Groups I and II).
No such changes were noted in Group III which
received only acetone. These results confirm
our previous findings that DMBA will cause
such changes in animals with growing hair as
well as those in the resting stages (6). The dis-
crepancy with the findings of others may be due
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TABLE I
0.1 ml. of 0.5% DMBA in
acetone (single dose)
2 wks. later start UVL
(total dose = 13.33 X
10 ergs/cm2)
0.1 ml. of 0.5% DMBA in
acetone (single dose)
0.1 ml. of acetone (single
dose)
2 wks. later start UVL
(total dose = 13.33 X
10 ergs/cm2)
Applied to posterior half
back after hair clipped
UVL applied at 3.4 cm. two
times a week for 67 weeks()
Applied to posterior half of
back after hair clipped
Applied to posterior half of
back after hair clipped
UVL applied as in Group I
Note: (X) Hair in growing stage (Boron dye method). () UVL applied Wednesday and Saturday of
each week
TABLE II
Effect of DMBA and UVL
Group
7 Days (X) 11 Days (X) 21 Days (X) 56 Days (X)
Male Female Male Female Male Female Male Female
I DMBAp1usIJVL
Hair loss
Thick and/or keratoses
II DMBA
Hair loss
Thick and/or keratoses
III Acetone plus TJVL
Hair loss
Thick and/or keratoses
11/15
?
18/19
11/19
0/31
1/31
15/16
?
20/22
18/22
0/16
0/16
15/15
13/15
19/19
19/19
0/31
2/31
16/16
16/16
22/22
21/22
0/16
0/16
(4')
14/15
19/19
13/19
(4')
—
25/31
(4')
16/16
21/22
20/22
(4')
—
12/16
(4')
15/15
3/19
0/19
(4')
—
13/31
(4')
16/16
5/22
2/22
(#)
——
3/15
Note: (X) Days after DMBA application; (4') Started UVL 14 days after DMBA applied.
Hair clipped with scissors prior to exposures when necessary.
to the combination of the specimen removal and
the application of the carcinogen (2, 7, 8, 9).
The skin of the mice in Group II which received
DMBA alone had returned to normal by fifty-six
days in most of the animals.
2. Reactions to UVL (Table III)
Ultraviolet light-induced thickening with or
without hyperkeratosis was noted in Group I
(DMBA and UVL) and Group III (acetone and
UVL). No significant reactions occurred in the
mice treated with acetone alone (Group III) until
the ultraviolet light exposures were initiated.
Almost all of these mice showed some thickening
of the exposed skin by seven days after starting
the light treatments. These changes were most
marked in Group I which was pretreated with
DMBA. The thickening of the exposed skin,
present in all of the mice in Group I at fifty-six
days, stood in contrast to the apparent clinical
normality of skin at fifty-six days in Group II.
3. Tumor Formation
In order to remain consistent with the litera-
ture, only individual growths appearing on the
posterior half of the back that reached the size
of approximately 8 cu. mm. (2 mm. in diameter
Group
No. of Mice
______________
Age in
Weeks (X)
Males Females
Procedure
Group I (DMBA plus
UVL)
Group II (DMBA)
Group III (Acetone
plus UVL)
Method
15
19
31
16
22
16
14 to 16
15 to 17
14 to 18
11 to 14
13 to 16
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TABLE III
Survivors (after DMBA or
Group Number
Acetone) No. Tumor
Bearing Mice
Total No.
Tumors
Total No.
Turnor( Re-
gressing
25 wks. 50 wks, 67 wks.
5
11
7
12
0
0
*1 DMBA plus UVL 15
16
d 9
13
2
9
2
4
*11 DMBA 19
22
d' 11
18
11
12
3
2
2
2
2
2
1 ? ()
1
*111 Acetone plus IJVL 31
16
ci' 31 25
12 11
7
0
0
0
0
0
0
0
Note: (,) Disappeared and returned; (*) Difference between Group I and Group II is significant
(Chi2p = <0.01)
at least) and persisted two weeks were considered
significant tumors.
a. Tumor onset: In Group I the first tumors
(2 such) appeared at sixty-seven days after
the application of the DMBA. The succeeding
tumors occurred in a random fashion throughout
the study (67 weeks).
The first tumor in Group II (DMBA) appeared
much earlier (at twenty-seven days), but no new
tumors occurred after forty-five days. No tumors
appeared in Group III (acetone and UVL).
Previous studies indicate that variations of five
weeks or more in tumor onset may not be sig-
nificant (2). The pattern of tumor appearances
will be discussed presently.
b. Tumor production: In Table III we see
that 16 of the 31 mice in Group I (DMBA and
TJVL) developed a total of 19 tumors by 67
weeks. In Group II (DMBA) 4 of the 41 animals
developed one tumor each. Analyzing our results
from the viewpoint of tumors per significant
numbers of survivors (the "survivors" included
mice that had died or been autopsied with sig-
nificant tumors before 55 weeks), we found 63
per cent of the 19 survivors in Group I had
tumors as compared to an 18 per cent incidence
in Group II (22 survivors), (Table IV). This
difference is statistically significant. No tumors
appeared in Group III (acetone and TJVL)
indicating that under the circumstances of this
experiment the total amount of ultraviolet
energy used (13.33 x 10 ergs per square centi-
meter) was subcarcinogenic. Therefore, we must
conclude that the ultraviolet light stimulated
the tumor growth initiated by the chemical
carcinogen.
c. Tumor size: Of the 19 tumors produced in
Group
Survivors
at 55 wks.
(after
DMBA)(5)
Tu-
mors
% Tumors
Bearing
Mice
*Group I DMBA
plus UVL (X)
*Group II DMBA ci'
*Group III Acetone
plus UVL (X)
6
13
12
10
23
11
5
7
2
2
0
0
83%}63%54
17%18.
20%1
0
0
Group I (DMBA and UVL 16 progressed to
the size of 100 Cu. mm. or more and 8 were larger
than 1000 cu. mm. None of the tumors of this
Group regressed. In Group II (DMBA) one
tumor completely disappeared and another almost
disappeared. Two reached a size greater than 100
cu. mm., one of which was larger than 1000 cu.
mm.
d. Plaque formation: In Group I the so-called
premalignant plaques appeared in 10 mice. Nine
of these appeared before thirty-five days and
one occurred at 66 weeks. Two of these plaques
developed into tumors. In Group II seven plaques
appeared all before thirty-five days. None de-
veloped into tumors. In Group III no plaques
or tumors appeared. In the present study 17
plaques appeared and only 2 became true tumors.
Also, of the total of 24 tumors produced, only 2
came from plaques. Thus the premalignant
potential of these lesions appears limited.
TABLE IV
Note: (X) Total UVL by 55 weeks = 12.06 X
10 ergs/cm2; () Includes dead mice with signifi-
cant tumors; (*) Difference between Group I and
Group II is significant (Chi2p = <0.01).
458 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
e. Influence of sex: At first glance it would
appear that the female mice were more susceptible
to carcinogenesis (Table III). However, in
Table IV we see that 83 per cent of the male
survivors had tumors by 55 weeks. Only 54
per cent of the females had tumors under the
same conditions. Thus the discrepancy noted
in Table III may be related to survival rather
than susceptibility to tumor formation.
f. Histology of tumors: Our histological studies
are not yet completed and will be reported later.
Preliminary investigations indicate that epidermal
and dermal malignancies were produced sepa-
rately and in combinations. Squamous cell
carcinomas were the most prevalent; some
keratoacanthomas occurred.
DI5CU5SION
The studies of Berenblum and others suggest
that chemical tumor formation is a two-stage
process (2—4). According to this concept the
first stage consists of initiation of tumor potential
or latent tumor cells by the carcinogen. The
second phase is called the promoting stage in
which stimulation or acceleration of tumor
growth is accomplished by repeated applications
of certain cocarcinogenic agents. The cocar-
cinogens may or may not have carcinogenic
potential within themselves. For example, a
single application of a carcinogen during the
growing phase of the hair cycle leads to few or
no tumors in experimental mice. However, if
croton oil (a non-carcinogen) is applied sub-
sequently, significant papilloma formation occurs.
Physical modalities including freezing, surgical
trauma and scalding all have been noted to have
cocarcinogenic properties (10, 11, 12).
The effect of ultraviolet light on chemical
carcinogenesis has been more difficult to evaluate
because of the carcinogenic potential of the
modality itself. In addition, photosensitization
effects by the carcinogen as well as photo-oxida-
tion and alteration of the carcinogen by light
energy have confused the picture (13, 14, 15).
Utilizing the two-stage concept of experimental
tumor formation, it has been possible for the
most part to eliminate these confusing factors.
In the present study, the hair cycle was es-
tablished at the onset and the ultraviolet energy
used was subcnrcinogenic in amount. The effects
of light on the carcinogen and photosensitization
by the carcinogen were removed by starting the
light exposures fourteen days after the applica-
tion of the DMBA. The carcinogen should no
longer have been present at that time (15).
Also, photo-recovery apparently played an in-
significant role in our study, perhaps due to the
limited visible light exposure allowed (16).
The results of this study indicate that ultraviolet
light shorter than 3200 A can act as a cocnr-
cinogen (promoter) as well as a carcinogen.
The co-carcinogenic properties of ultraviolet
light in our studies differed from the effect of
noncarcinogenic chemical promoters. With these
substances, relatively large numbers of tumors
are produced per animal, occurring at two peaks—
one early in the experiment and another after
30 weeks (17). The majority of these growths
regress and only a few are histologically malig-
nant. In contrast, the ultraviolet light-promoted
tumors were few in number, did not regress, and
occurred at irregular periods throughout the
study. All the individual tumors became very
large and the great majority were malignant.
These findings suggest that substances or
modalities with carcinogenic potential will pro-
mote more progressive tumor growth. The fact
that chemical carcinogens when used in a promot-
ing capacity cause progressive tumor formation
and malignancy supports this view (18).
The types of malignancy reported as produced
by different modalities vary greatly. Chemically
induced cancers are usually epidermal in origin
when the carcinogen is applied topically (19).
In contrast, Blum noted n 90 per cent sarcoma
incidence in his studies of ultraviolet light
carcinogenesis using the ears of albino mice as
the test sites (1). In our study both epidermnl
carcinomas and sarcomas occurred. In contrast
to Blum's findings, the epidermal tumors were
in the majority, though some stromal changes
were not uncommon. This discrepancy between
our fixidings and those of Blum may reflect the
fact we used the back of the mouse as the ex-
posure site insted of the ears. Winklemann
produced only epidermnl cancers on the backs of
hairless mice with ultraviolet light (20). Another
possibility is that initiation of tumor growth
by a chemical carcinogen in our study may have
influenced the type of lesions produced.
The mechanism of the co-carcinogenesis is
uncertain. All promoters (co-carcinogens) pro-
duce epidermal hyperplasia (21). However, Rusch
suggested that the significant action of promotion
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was to stimulate mitotic activity (22). Berenbium
added that not only mitosis stimulation but a
highly specific delay in cell maturation was
essential to the process (23). Stella's studies
support Berenblum's concept (24). He found
that hyperplasia produced in mouse skin by
promoters alone showed mitoses in the basal
layer only; all of the daughter cells died by
progressive maturation. If a carcinogen was
applied before the promoter, mitotic activity,
cellular atypism and delayed maturation occurred
throughout the epidermis. He emphasized that
frequent repeated applications of the promoter
were vital for successful promotion. Decreasing
the time between applications significantly re-
duced the total amount of co-carcinogen needed.
In contrast, Orr's studies suggested that the
main carcinogenic effect may be on the dermal
connective tissue (19). According to this view,
hyperplasia per se is not a prerequisite for
eareinogenesis, and chemical tumor initiation
does not occur primarily in the epidermis. The
question of where the co-carcinogenic effect of
light energy fits in this picture is difficult to
evaluate. Ultraviolet light rays shorter than
3200 A cause epidermal hyperplasia. In addition
they have a direct effect on the mouse dermis
because the thin epidermis transmits these
wavelengths. Blum noted a high per cent of
sarcoma formation in his extensive studies on
ultraviolet eareinogenesis. He interpreted this
to indicate an important effect of the ultraviolet
light on the corium of his experimental animals.
Further work is required to decide which of
these views is the correct one.
SUMMARY AND CONCLUSIONS
1. The effects of repeated small doses of
ultraviolet light rays shorter than 32000 A on
tumors initiated by 9:10 dimethyl-1 :2 benz-
anthracene (DMBA) were investigated utilizing
the two stage concept of chemical tumor forma-
tion.
2. When the DMBA was applied during the
growing stage of the hair cycle, 4 of 41 mice
developed a total of four tumors in 67 weeks.
Of 31 mice 16 developed 19 tumors when the
DMBA was followed by ultraviolet light ex-
posures twice weekly for 67 weeks. No tumors
occurred in the mice that received only ultra-
violet and no DMBA, indicating that sub-
carcinogenic amounts of light were used. From
these results we concluded that the light
energy promoted the DMBA induced tumor
formation.
3. The tumors produced by the influence of
the ultraviolet light exposures on the DMBA
treated mice grew to large proportions and did
not regress. The large majority showed malignant
histologic pictures. Both squamous cell car-
cinomas and fibrosarcomas were seen; however,
there were a greater number of epidermal
malignancies.
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DISCUSSION
Da. M. A. PATHAK, Boston, Mass.: I want
to compliment Dr. Epstein for this beautiful
presentation. I would like to ask two questions:
(1) Have you studied the photosensitivity of
DMBA? and (2) Why did you select the back
of the animal for irradiation? Using one ear of
the mice as control, and the other ear as treated
with DMBA, and keeping one group in dark
and the other in light, you would obtain a better
relation in proving the co-carcinogenic effect of
ultraviolet light. This method was originally
described by Drs. Knox and Griffin of Houston.
DE. PETER FLESdH, Philadelphia, Pa.: My
question is somewhat related to that of Dr.
Pathak: Wouldn't it be a good idea to irradiate
the carcinogenic agent in vitro and then apply
oltraviolet light? You may get a higher in-
cidence of tumors than with the non-irradiated
carcinogen.
Da. JOHN H. EPsTEIN, (in closing): In answer
to Dr. Pathak's and Dr. Flesch's questions, we
were concerned with eliminating the photo-
sensitizing effects of DMBA in our study. For-
tunately DMBA remains in the mouse skin for a
limited period. If the carcinogen is applied during
the resting phase of the hair cycle it will remain
for about ten days. If applied during the growing
stage no detectable carcinogen will be found
three days later. Therefore by using the growing
stage of the hair cycle and starting the ultraviolet
fourteen days after the single application of the
carcinogen, the effect of the light energy on the
DMBA and of the DMBA on the light was
eliminated.
Concerning Dr. Pathak's second question,
we used the back of the animal instead of the
ears for two reasons. First, the tumors produced
in the ears by ultraviolet rays have been sarcomas
for the most part. We were interested in producing
epidermal tumors if possible. DMBA is an
epidermal tumor initiater when applied topically
to the skin and much of the previous work with
this carcinogen has been on the back of mice.
Therefore we felt our chances of producing
epidermal tumors might be better in this area
than on the ears because of the thickness of the
skin, the presence of hair follicles and the ex-
periences of previous workers.
The second reason was that with our instru-
mentation, the back of the animal was the
simplest location to expose to the ultraviolet
light.
